News

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.
HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal Medicine.
WARMINSTER, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, ...
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
The renewal of the PACIC comes amid ongoing inflationary pressures that are impacting low-income families in Mexico.
More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.
A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.
San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...
The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a ...
Super Micro Computer ( SMCI) retained the top spot for the most shorted S&P 500 ( SP500) stock as a percentage of float in ...